Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122615002 | 12261500 | 2 | F | 20160802 | 20160413 | 20160805 | EXP | FR-AFSSAPS-AM20160390 | FR-009507513-1604FRA004393 | MERCK | 0.00 | F | Y | 0.00000 | 20160805 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122615002 | 12261500 | 1 | PS | ESMERON | ROCURONIUM BROMIDE | 1 | Intravenous (not otherwise specified) | UNK | 20214 | SOLUTION FOR INJECTION | |||||||||
| 122615002 | 12261500 | 2 | SS | SUFENTANIL | SUFENTANIL | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 122615002 | 12261500 | 3 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122615002 | 12261500 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122615002 | 12261500 | Anaphylactic shock | |
| 122615002 | 12261500 | Generalised tonic-clonic seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122615002 | 12261500 | 1 | 20160316 | 20160316 | 0 | |
| 122615002 | 12261500 | 2 | 20160316 | 20160316 | 0 | |
| 122615002 | 12261500 | 3 | 20160316 | 20160316 | 0 |